Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
1. 系统已在2026-04-17 11:58:20对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1111/bph.70376
文献链接: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.70376
其他信息:
出版社: Wiley
作者: Andreas Papapetropoulos; Stavros Topouzis; Steve P. H. Alexander; Miriam M. Cortese‐Krott; Zsuzsanna Helyes; Kirill Martemyanov; Claudio Mauro; Nithyanandan Nagercoil; Reynold A. Panettieri; Hemal H. Patel; Rainer Schulz; Barbara Stefanska; Gary J. Stephens; Nathalie Vergnolle; Xin Wang; Stephen Ward; Péter Ferdinandy
全文下载地址: https://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/bph.70376
